Molecular Devices Launches Automated System for Microbial Colony Picking
Molecular Devices has introduced the QPix FLEX Microbial Colony Picking System, a compact, automated platform for microbial colony screening. The …
All Posts
Atropos Health Adds Ontada Oncology Data to Expand Community Cancer Coverage in Real-World Evidence Network
Atropos Health has integrated data from Ontada, a McKesson company focused on community oncology, into the Atropos Evidence Network. The …
Deep Genomics Releases AI Foundation Model for microRNA Binding and mRNA Degradation Prediction
Deep Genomics has introduced REPRESS, a deep learning model trained to predict microRNA (miRNA) binding and mRNA degradation directly from …
Datavant to Acquire Aetion, Expanding Into End-to-End Real-World Evidence Analytics for Life Sciences
Datavant has announced its acquisition of Aetion, a real-world evidence (RWE) platform used by regulators and biopharma companies to assess …
Dementia Discovery Fund Closes Second Fund at $269M, Bringing Total Raised to Over $550M
The Dementia Discovery Fund (DDF), managed by SV Health Investors, has closed its second fund, DDF-2, at $269 million, bringing …
NIH BRAIN Initiative Backs Toolkit of 1,000+ Enhancer AAVs for Cell-Type Targeting in Brain Disorders
A consortium of researchers led by the Allen Institute, with collaborators from over two dozen U.S. institutions including Harvard, Broad, …
Phesi Analyzes 167M Patient Records, Finds Colorectal Cancer Has Largest Oncology RWD Volume
Phesi has released a new analysis based on 167 million patient records processed via its Trial Accelerator platform, highlighting substantial …
HP and Tecan Launch Combined Single-Cell and Reagent Dispenser, Report 40x Faster Dosing for Drug Discovery
HP and Tecan have launched the Duo Digital Dispenser, a system that combines single-cell isolation and reagent dispensing in one …
Experity Rolls Out AI-Integrated Partner Ecosystem to Streamline Urgent Care Operations
Experity has launched a Partner Ecosystem aimed at integrating AI-based tools into urgent care operations. The initiative, announced this week, …
AI Model Reconstructs 3D Human Faces from DNA with High Accuracy
A new study has introduced Difface, an AI-based framework capable of reconstructing 3D human facial images directly from DNA, demonstrating …
Boehringer Ingelheim Taps Tempus’ AI and Patient Data to Deepen Cancer Research Pipeline
Tempus has entered a strategic multi-year collaboration with Boehringer Ingelheim to support the expansion of Boehringer’s oncology pipeline using AI …
Regeneron Acquires 23andMe Assets for $256M to Expand Consumer Genomics and Data-Driven Drug Discovery
Regeneron has announced an agreement to acquire substantially all assets of 23andMe for $256 million, following a bankruptcy auction process. …